HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: iovs.07-1344v1 49/6/2483    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Yang, X. Articles by Tezel, G. Search for Related Content PubMed PubMed Citation Articles by Yang, X. Articles by Tezel, G.

Phosphorylation-Dependent Interaction with 14-3-3 in the Regulation of Bad Trafficking in Retinal Ganglion Cells

¹From the Departments of Ophthalmology and Visual Sciences, ²Pharmacology and Toxicology, and ³Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky.

PURPOSE. To focus on the proteomic analysis of 14-3-3 proteins and to determine their cellular localization and functional role during glaucomatous neurodegeneration.

METHODS. Complementary proteomic approaches were used to identify phosphorylated proteins in a chronic pressure-induced rat model of glaucoma. To detect interacting proteins, specific protein complexes were eluted using coimmunoprecipitation and recombinant protein-based affinity pull-down for subsequent mass spectrometric analysis. Western blot analysis was performed for validation of the proteomic findings, and immunohistochemical analysis of rat eyes and human donor eyes determined the cellular localization of 14-3-3 proteins. In addition, in vivo treatment experiments were conducted using JNK and protein phosphatase inhibitors.

RESULTS. Findings of mass spectrometry, Western blotting, and tissue immunolabeling revealed the presence of different 14-3-3 isotopes in RGCs and their up-regulation and phosphorylation during glaucomatous neurodegeneration. Consecutive experiments through proteomic analysis identified various proteins interacting with 14-3-3, which included calmodulin and a proapoptotic member of the Bcl-2 family, Bad; 14-3-3 was found to keep phospho-Bad sequestered in the cytoplasm. However, this association was disrupted in ocular hypertensive eyes in correlation with Bad dephosphorylation and 14-3-3 phosphorylation, thereby leading to mitochondrial translocation of Bad for apoptotic function. Inhibition of JNK activity and of protein phosphatase activity complementarily secured the 14-3-3-scaffold of Bad in the cytoplasm and preserved optic nerve axons in ocular hypertensive eyes.

CONCLUSIONS. Findings of this in vivo study identify that an important protein family associated with checkpoint control pathways, 14-3-3, is involved in cellular signaling during glaucomatous neurodegeneration in a phosphorylation-dependent manner.

This article has been cited by other articles:

				G. Tezel and the Fourth ARVO/Pfizer Ophthalmics Research Instit The Role of Glia, Mitochondria, and the Immune System in Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1001 - 1012. [Full Text] [PDF]

				I. Surgucheva, V. I. Shestopalov, and A. Surguchov Effect of {gamma}-Synuclein Silencing on Apoptotic Pathways in Retinal Ganglion Cells J. Biol. Chem., December 26, 2008; 283(52): 36377 - 36385. [Abstract] [Full Text] [PDF]